Raging Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Raging Capital Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-295,790	Closed	-$1.37M	–	52
2019 Q1	$1.37M	Buy	295,790 +10,787	+4%	+$51.1K	0.2%	39
2018 Q4	$998K	Buy	+285,003	New	+$1.98M	0.14%	52
2016 Q4	–	Sell	-73,760	Closed	-$870K	–	67
2016 Q3	$870K	Hold	73,760	–	–	0.12%	40
2016 Q2	$954K	Hold	73,760	–	–	0.15%	38
2016 Q1	$1.18M	Buy	+73,760	New	+$1.4M	0.18%	35

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Raging Capital Management's INSY Position: Q2 2019 in Review

Raging Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 295,790 shares — an estimated $1.37M sold.

Raging Capital Management first reported a position in INSY in Q1 2016 and held it in 5 quarters. The position peaked at $1.37M in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Raging Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Raging Capital Management sold 295,790 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1.37M.
Raging Capital Management first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 5 quarters.
Raging Capital Management's Insys Therapeutics, Inc. position peaked at $1.37M in Q1 2019.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Raging Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.